← Back
$TVTX All transactions

Travere Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$12K

Shares

815

Price

$15

Filed

Jul 2

Insider

Name

Inrig Jula

Title

CHIEF MEDICAL OFFICER

CIK

0001902368

Roles

Officer

Transaction Details

Transaction Date

2025-07-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

88,787

Footnotes

This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in February 2025.

Filing Info

Accession No.

0001415889-25-019108

Form Type

4

Issuer CIK

0001438533

Inrig Jula's History

Date Ticker Type Value
2026-04-15 TVTX $43K
2026-04-13 TVTX A $0
2026-02-04 TVTX $50K
2026-02-04 TVTX $8K
2026-02-03 TVTX $223K
2026-01-31 TVTX A $0
2026-01-31 TVTX A $0
2026-01-06 TVTX $17K
2026-01-05 TVTX $82K
2025-12-24 TVTX M $134K

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.5M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$765K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$9.5M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
$235K 2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$1.0M 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$324K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$638K 2026-04-15